Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Applying Precision Medicine to Ovarian Cancer: Proof-of-Principle for a "Molecular Second Look".

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society - 1 Mar 2018

Schwartz Melissa, Camacho-Vanegas Olga, Wood Ashley M, Dashkoff Matthew, Whitelock Courtney, Harkins Timothy T, Cohen Carmel J, Beddoe Ann Marie, Dottino Peter, Martignetti John A

Abstract excerpt

OBJECTIVES: The objectives of this study were to assess if targeted investigation for tumor-specific mutations by ultradeep DNA sequencing of peritoneal washes of ovarian cancer patients after primary surgical debulking and chemotherapy, and clinically diagnosed as disease free, provides a more sensitive and specific method to assess actual treatment response and tailor future therapy and to compare this...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alleles
Share to Cystadenocarcinoma, Serous

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DNA Mutational Analysis

Share to DNA, Neoplasm

Share to High-Throughput Nucleotide Sequencing

Share to Ovarian Neoplasms

Share to Precision Medicine

Share to Proof of Concept Study

Source

Open in PubMed Open full text

Identifiers

PMID: 29324546
DOI: 10.1097/IGC.0000000000001190
PMCID: PMC5839702

Genes

MSH6

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Applying Precision Medicine to Ovarian Cancer: Proof-of-Principle for a "Molecular Second Look".PMID 29324546Read ↗

Application of precision medicine based on next-generation sequencing and immunohistochemistry in ovarian cancer: a real-world experience.Semantic proximity Read ↗

Next Generation Sequencing and Molecular Biomarkers in Ovarian Cancer—An Opportunity for Targeted TherapySemantic proximity Read ↗

Molecular analysis for ovarian cancer detection in patient-friendly samplesSemantic proximity Read ↗

A SNaPshot of potentially personalized care: Molecular diagnostics in gynecologic cancer.Semantic proximity Read ↗

Comprehensive genomic profiling of epithelial ovarian cancer by next generation sequencing-based diagnostic assay reveals new routes to targeted therapiesSemantic proximity Read ↗

Serial Circulating Tumor DNA Analysis with a Tumor-Naïve Next-Generation Sequencing Panel Detects Minimal Residual Disease and Predicts Outcome in Ovarian Cancer.Semantic proximity Read ↗

Comprehensive genomic evaluation of advanced and recurrent breast cancer patients for tailored precision treatmentsSemantic proximity Read ↗

Cell-free DNA from ascites identifies clinically relevant variants and tumour evolution in patients with advanced ovarian cancerSemantic proximity Read ↗

Comprehensive genomic evaluation of advanced and recurrent breast cancer patients for tailored precision treatments.Semantic proximity Read ↗

Utility of a custom designed next generation DNA sequencing gene panel to molecularly classify endometrial cancers according to The Cancer Genome Atlas subgroups.Semantic proximity Read ↗

Uterine lavage identifies cancer mutations and increased TP53 somatic mutation burden in individuals with ovarian cancer.Semantic proximity Read ↗

Ultra-sensitive sequencing for cancer detection reveals progressive clonal selection in normal tissue over a century of human lifespanSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.